▶ 調査レポート

シノプフォアのグローバル市場(2023~2028):診断、治療

• 英文タイトル:Synoptophore Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)

Mordor Intelligenceが調査・発行した産業分析レポートです。シノプフォアのグローバル市場(2023~2028):診断、治療 / Synoptophore Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028) / MRC2303I0164資料のイメージです。• レポートコード:MRC2303I0164
• 出版社/出版日:Mordor Intelligence / 2023年1月23日
• レポート形態:英文、PDF、115ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥712,500 (USD4,750)▷ お問い合わせ
  Corporate License¥1,312,500 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Mordor Intelligence社の本調査レポートでは、世界のシノプフォア市場規模が、予測期間中に年平均4%で成長すると予測しています。本書では、シノプフォアの世界市場について調べ、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、用途別(診断、治療)分析、器械種類別(手動、自動)分析、エンドユーザー別(病院、診療所、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ、アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、その他)分析、競争状況、市場機会・将来の動向など、以下の構成でまとめております。また、HAAG-STREIT GROUP、APPASAMY ASSOCIATES、Prkamya Visions、Nanjing Redsun Optical Co., Ltd、Gem Optical Instruments Industries、Dahlgren India、Rumax International、66 Vision Tech Co., Ltdなどの企業情報が含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向

・世界のシノプフォア市場規模:用途別
- 診断用シノプフォアの市場規模
- 治療用シノプフォアの市場規模

・世界のシノプフォア市場規模:器械種類別
- 手動型シノプフォアの市場規模
- 自動型シノプフォアの市場規模

・世界のシノプフォア市場規模:エンドユーザー別
- 病院における市場規模
- 診療所における市場規模
- その他エンドユーザーにおける市場規模

・世界のシノプフォア市場規模:地域別
- 北米のシノプフォア市場規模
アメリカのシノプフォア市場規模
カナダのシノプフォア市場規模
メキシコのシノプフォア市場規模

- ヨーロッパのシノプフォア市場規模
ドイツのシノプフォア市場規模
イギリスのシノプフォア市場規模
フランスのシノプフォア市場規模

- アジア太平洋のシノプフォア市場規模
中国のシノプフォア市場規模
インドのシノプフォア市場規模
日本のシノプフォア市場規模

- その他地域のシノプフォア市場規模
・競争状況
・市場機会・将来の動向

The synoptophore market is projected to register a CAGR of around 4% during the forecast period.

The COVID-19 pandemic caused healthcare services to reduce eye care activities, as examination procedures in ophthalmology involve close interactions with the patients, which increases the risk of infection. The American Academy of Ophthalmology (AAO recommended ophthalmologists halt non-emergency care. According to a 2021 membership survey of 416 members conducted by the AAPOS, devastating and potential impacts were observed on pediatric ophthalmology practices during the COVID-19 pandemic. Children could not get proper treatment at the right time due to restrictions on non-essential visits to eye clinics, which hampered the overall market.

The growth of the studied market can be largely attributed to the increasing incidences of visual acuity disorders, growing awareness about the early diagnosis of visual acuity disorders, and the rising demand for non-invasive processes.

Increasing incidences of visual acuity disorders contribute to the rising demand for synoptophore. Risk factors, such as stroke and traumatic head injury, associated with visual acuity disorders also increased over time. Synoptophore devices are considered reliable for the correction of such disorders. As per the 2021 statistics by the National Eye Institute (NEI), around 5% to 16% of people suffer from convergence insufficiency (CI) disorder. The young and adult population is more prone to visual acuity disorders, which augments the growth of the market studied.

Growing awareness about the early diagnosis of acuity disorders is anticipated to fuel market growth. Several orthoptic associations encourage the early diagnosis of acuity disorders, which fuels the demand for synoptophore devices. As per a 2021 article by the International Orthoptic Association (IOA), the Brazilian Orthoptic Association determines the first Monday in June as the “World Orthoptic Day.” According to the International Agency for the Prevention of Blindness (IAPB), World Sight Day (WSD) is an annual day of awareness held to focus global attention on blindness and vision impairment. Such initiatives increase the early diagnosis of visual acuity disorders, thereby propelling the demand for synoptophore.

However, the high cost of synoptophore devices and access to alternatives for treating visual acuity disorders are some factors impeding the market growth.

Synoptophore Market Trends

Therapeutic Application is Expected to Witness a Significant Growth Over the Forecast Period

By application, the therapeutic segment is expected to witness significant growth over the forecast period. Synoptophore device is majorly used in the treatment of ocular motility disorders. It performs the most comprehensive binocular vision assessment and is reliable. Standard measurements allow assessment of fusional amplitudes, simultaneous perception, and stereopsis in case of abnormal retinal correspondence or horizontal, vertical, or torsional ocular misalignment.

A 2021 IEEE Conference revealed that synoptophore is increasingly used for binocular vision (BV). Synoptophore evaluates three grades of BV. As per the 2020 statistics by the American Academy of Ophthalmology (AAO), the prevalence of anisometropic amblyopia is about 5.2% in children. As per the same source, amblyopia is the most common cause of low visual acuity in children and adults in developed countries, with an incidence of 3% to 6%. The success rate via occlusion therapy is not very promising, and vision is improved to a high degree using a synoptophore to stimulate the amblyopic eye. Therefore, the demand for synoptophore devices helps healthcare facilities treat visual acuity disorders.

Thus, given the above-mentioned factors, the segment is expected to grow significantly over the forecast period.

North America is Dominant Region in the Synoptophore Market

In North America, the market in the United States is anticipated to witness significant growth over the forecast period. Major factors contributing to the growth of the market in the country are the increasing incidence of visual acuity disorders, such as strabismus and amblyopia, and the rising inclination for non-surgical treatment procedures.

As per the 2021 statistics by Prevent Blindness, in the United States, more females than males experience permanent vision loss in the ratio of 3 females for every 2 males. This fuels the adoption of vision correction using synoptophore. Moreover, increasing research and development in the region is anticipated to fuel the demand for synoptophore devices. For instance, in the United States, as per a 2021 update by the Research to Prevent Blindness (RPB), it provides major eye research funding to 37 leading scientific institutions and supports the work of vision scientists engaged in a diverse range of disease-oriented research. Furthermore, the technologically advanced infrastructure of North America is anticipated to fuel the production of advanced automatic synoptophore devices.

Thus, given the above-mentioned factors, the synoptophore market is anticipated to grow significantly over the forecast period in North America.

Synoptophore Market Competitor Analysis

The synoptophore market is nearly fragmented due to the presence of several regional and global market players. These players focus on growth strategies, such as new product launches, innovations in existing products, and mergers and acquisitions. Key market players in the global market are HAGG-STREIT GROUP, APPASAMY ASSOCIATES, Prkamya Visions, Nanjing Redsun Optical Co., Ltd, Rumax International, and Gem Opticals Instruments Industries. These players are also involved in strategic alliances, such as acquisitions and collaborations, to secure their position in the global market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
レポート目次

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidences of Visual Acuity Disorders
4.2.2 Growing Awareness on the Early Diagnosis of Visual Acuity Disorder
4.2.3 Rising Demand for Non-invasive Procedures
4.3 Market Restraints
4.3.1 High Cost of Synoptophore Device
4.3.2 Access to Alternative Treatments
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size – Value in USD million)
5.1 By Application
5.1.1 Diagnostic
5.1.2 Therapeutic
5.2 By Instrument Type
5.2.1 Manual
5.2.2 Automatic
5.3 By End User
5.3.1 Hospitals
5.3.2 Clinics
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Rest of the World

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 HAAG-STREIT GROUP
6.1.2 APPASAMY ASSOCIATES
6.1.3 Prkamya Visions
6.1.4 Nanjing Redsun Optical Co., Ltd
6.1.5 Gem Optical Instruments Industries
6.1.6 Dahlgren India
6.1.7 Rumax International
6.1.8 66 Vision Tech Co., Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS